Gilead Sciences GILD
NASDAQ GILD
$168.08 +0.13 (+0.08%)
At close: Nov 13, 2026 · 4:00 PM EST

Gilead Sciences (GILD) Cash from Discontinued Operations (2009 - 2010)

Updated

Analysis

Gilead Sciences (GILD) Cash from Discontinued Operations (2009 - 2010) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 6.56 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 136.55 Bn 104.28 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2010 739.42 Mn
Jun 30, 2010 699.08 Mn
Mar 31, 2010 670.57 Mn
Jun 30, 2009 622.92 Mn
Mar 31, 2009 641.33 Mn
API Access

Gilead Sciences Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=GILD&period=max&api_key=YOUR_API_KEY